Immediate Impact
2 hit
Citing Papers
Exploiting innate immunity for cancer immunotherapy
2023 Hit
Moving towards personalized treatments of immune-related adverse events
2020 Hit
Works of Robert J. Van Gulick being referenced
Circulating CD8 + mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patients
2022
Biomarkers to predict immune-related adverse events with checkpoint inhibitors.
2019